Evidence map›Paper›PMID 30602984›Full record

ArticleAfrican health sciences2018

Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan.

Bushra B Patoli, Atif A Patoli, Nimerta Kumari Balani, Ashfaque A Korejo

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bushra B PatoliInstitute of Microbiology, University of Sindh, Jamshoro. Pakistan.
Atif A PatoliInstitute of Microbiology, University of Sindh, Jamshoro. Pakistan.
Nimerta Kumari BalaniInstitute of Microbiology, University of Sindh, Jamshoro. Pakistan.
Ashfaque A KorejoInstitute of Microbiology, University of Sindh, Jamshoro. Pakistan.
University of Sindh · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPakistan is endemic to hepatitis B and C infections. Alarming rise in hepatitis C virus (HCV) infection has been noticed in some areas of Sindh with an increasing risk for co-infection frequency in this region.

objectiveTo estimate the burden of HBV/HCV infection in Hyderabad Pakistan.

methodsELISA and Nucleic acid Amplification test were performed to detect viruses. SPSS and online calculator were used for statistical analysis.

resultsFrom a total of 108 seropositive hepatitis patients, 36.1% (n=39) were found HCV RNA-positive. Non-significant differences were observed in the frequencies of HCV infection for both genders [OR=0.735, CI (95%) 0.307-1.761, p<0.05]. The percentage of HBV DNA detection among 108 HCV-seropositive cases was 17.9% (n=19). However, HCV-HBV co-infection in HCV-RNA positive cases was determined in 48.7% (n=19) cases with non-significant difference in both genders [OR=1.51, CI (95%) = 0.38 - 5.96, p< 0.05]. Analysis suggested weakly positive correlation between HCV mono-infection and HCV-HBV co-infection and age (r =0.184, and r =0.1231), respectively.

conclusionThe study demonstrates a high prevalence of HBV co-infection among active hepatitis C patients of Hyderabad.

Indexed as

AdultAgedCoinfectionEnzyme-Linked Immunosorbent AssayFemaleHepacivirusHepatitis AntibodiesHepatitis BHepatitis B virusHepatitis CHumansMaleMiddle AgedNucleic Acid Amplification TechniquesPakistanPrevalenceHepatitis AntibodiesRNA, Viralactive hepatitis CHCV-HBV co-infectionHCV mono-infectionHyderabadmolecular surveillanceNucleic acid Amplification TestSindh

Identifiers

PMID30602984
PMCPMC6307001
OpenAlexW2886537638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.